ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,000 | -68.6% | 300 | -76.9% | 0.01% | -66.7% |
| Q2 2019 | $35,000 | 0.0% | 1,300 | 0.0% | 0.03% | 0.0% |
| Q1 2019 | $35,000 | +66.7% | 1,300 | 0.0% | 0.03% | +68.8% |
| Q4 2018 | $21,000 | -22.2% | 1,300 | 0.0% | 0.02% | -11.1% |
| Q3 2018 | $27,000 | +350.0% | 1,300 | +225.0% | 0.02% | +350.0% |
| Q2 2018 | $6,000 | -86.4% | 400 | -79.5% | 0.00% | -76.5% |
| Q1 2018 | $44,000 | -13.7% | 1,950 | +15.1% | 0.02% | +6.2% |
| Q4 2017 | $51,000 | -3.8% | 1,694 | +20.1% | 0.02% | -5.9% |
| Q3 2017 | $53,000 | +26.2% | 1,411 | -6.6% | 0.02% | +13.3% |
| Q2 2017 | $42,000 | +20.0% | 1,511 | +50.3% | 0.02% | +7.1% |
| Q1 2017 | $35,000 | +40.0% | 1,005 | +17.5% | 0.01% | +55.6% |
| Q4 2016 | $25,000 | +78.6% | 855 | +87.9% | 0.01% | +80.0% |
| Q3 2016 | $14,000 | +40.0% | 455 | +51.2% | 0.01% | 0.0% |
| Q2 2016 | $10,000 | +25.0% | 301 | +0.3% | 0.01% | +66.7% |
| Q1 2016 | $8,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |